Clincosm LogoSign in Get a demo

mesothelioma

Showing 26 - 50 of 162
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +10 more
  • Singapore, Singapore
    Novartis Investigative Site
Nov 16, 2022

Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)

Recruiting
  • Nasopharyngeal Carcinoma
  • +8 more
  • Springdale, Arkansas
    Highlands Oncology
Nov 11, 2022

Malignant Pleural Disease, Mesothelioma, Metastases Trial in United States (iCasp9M28z T cell infusions, cyclophosphamide,

Active, not recruiting
  • Malignant Pleural Disease
  • +4 more
  • iCasp9M28z T cell infusions
  • +2 more
  • Basking Ridge, New Jersey
  • +5 more
Nov 14, 2022

Mesothelioma Trial in Canada, France, Italy (Cisplatin, Pemetrexed, Pembrolizumab)

Active, not recruiting
  • Mesothelioma
  • Calgary, Alberta, Canada
  • +56 more
Nov 8, 2022

Malignant Pleural Effusion, Malignant Pleural Mesothelioma, Mesothelioma Trial in Leicester (RSO-021)

Recruiting
  • Malignant Pleural Effusion
  • +3 more
  • Leicester, United Kingdom
  • +5 more
Oct 28, 2022

Mesothelioma, Pleural Mesothelioma, Malignant Pleural Mesothelioma Trial in Australia, New Zealand, United States (Durvalumab,

Recruiting
  • Mesothelioma
  • +2 more
  • La Jolla, California
  • +56 more
Oct 24, 2022

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

Recruiting
  • Adenocarcinoma
  • +75 more
  • Biomarker Testing (L)
  • +2 more
  • Idaho Falls, Idaho
  • +1 more
Oct 18, 2022

Lung Cancer, Mesothelioma Trial in Houston (Alisertib)

Completed
Has Results
  • Lung Cancer
  • Mesothelioma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 23, 2022

Mesothelioma Trial in Worldwide (ADI-PEG 20 plus Pem Cis, Placebo plus Pem Cis)

Completed
  • Mesothelioma
  • ADI-PEG 20 plus Pem Cis
  • Placebo plus Pem Cis
  • Phoenix, Arizona
  • +44 more
Sep 30, 2022

Mesothelioma Trial in United States (pevonedistat, Pemetrexed and cisplatin)

Active, not recruiting
  • Mesothelioma
  • Basking Ridge, New Jersey
  • +7 more
Sep 12, 2022

Non Small Cell Lung Cancer, Mesothelioma Trial in Netherlands (Pemetrexed)

Recruiting
  • Non Small Cell Lung Cancer
  • Mesothelioma
  • 's-Hertogenbosch, Netherlands
  • +4 more
Sep 9, 2022

Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, nab-paclitaxel)

Completed
Has Results
  • Mesothelioma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 28, 2022

Rapid Autopsy and Procurement of Cancer Tissue

Recruiting
  • Thymus Tumors
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

    Recruiting
    • Mesothelioma
    • +14 more
    • Los Angeles, California
    • +13 more
    Aug 16, 2022

    Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors Trial in United States (MRTX1719)

    Recruiting
    • Mesothelioma
    • +5 more
    • Denver, Colorado
    • +5 more
    Aug 8, 2022

    Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

    Active, not recruiting
    Has Results
    • Metastatic Cancer
    • +9 more
    • Mobile, Alabama
    • +19 more
    Aug 1, 2022

    Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

    Recruiting
    • Gastric Cancer
    • +9 more
    • Tumor Infiltrating Lymphocytes (TIL)
    • Fludarabine + Cyclophosphamide combination
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jul 21, 2022

    Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)

    Recruiting
    • Pancreatic Cancer
    • +15 more
    • Grand Rapids, Michigan
    • +2 more
    Jul 18, 2022

    Mesothelioma, Mesotheliomas Pleural, Mesothelioma, Malignant Trial in Bethesda, Nashville (TC-510, Fludarabine,

    Recruiting
    • Mesothelioma
    • +14 more
    • TC-510
    • +2 more
    • Nashville, Tennessee
      Sarah Cannon Research Institute
    Jul 14, 2022

    Frequency and Clinical Phenotype of BAP1 Hereditary

    Recruiting
    • Uveal Melanoma
    • +7 more
      • Columbus, Ohio
        The Ohio State University Wexner Medical Center
      Jul 6, 2022

      Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, ipilimumab)

      Recruiting
      • Mesothelioma
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jul 6, 2022

      Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)

      Recruiting
      • Pancreatic Cancer
      • +15 more
      • Gilbert, Arizona
      • +4 more
      Jun 21, 2022

      NSCLC, Mesothelioma, Bladder Cancer Trial in Augusta (Bosutinib, Pemetrexed)

      Completed
      • Carcinoma, Non-Small-Cell Lung
      • +7 more
      • Augusta, Georgia
        Augusta University Georgia Cancer Center
      Jun 10, 2022

      All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,

      Active, not recruiting
      • All Malignancies
      • +11 more
      • Encinitas, California
      • +9 more
      May 20, 2022